Channel Therapeutics Corporation
CHRO
$1.12
$0.032.75%
AMEX
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 513.40K | 1.25M | 2.41M | 3.77M | 96.40K |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 65.30K | 94.60K | 158.10K | 220.90K | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 790.40K | 790.40K | 40.40K | 40.40K | -- |
Total Current Assets | 1.37M | 2.14M | 2.60M | 4.03M | 96.40K |
|
|||||
Total Current Assets | 1.37M | 2.14M | 2.60M | 4.03M | 96.40K |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 1.37M | 2.14M | 2.60M | 4.03M | 96.40K |
|
|||||
Total Accounts Payable | 1.90M | 1.28M | 835.40K | 2.41M | 4.62M |
Total Accrued Expenses | -- | 300.00 | 363.40K | 493.90K | 645.90K |
Short-term Debt | 2.19M | 2.29M | 1.59M | -- | 1.27M |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | 5.40K |
Total Other Current Liabilities | -- | -- | -- | -- | 5.40K |
Total Current Liabilities | 4.08M | 3.57M | 2.79M | 2.90M | 6.54M |
|
|||||
Total Current Liabilities | 4.08M | 3.57M | 2.79M | 2.90M | 6.54M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 2.19M | 2.29M | 1.59M | -- | 1.27M |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 4.08M | 3.57M | 2.79M | 2.90M | 6.54M |
|
|||||
Common Stock & APIC | 18.76M | 18.12M | 17.67M | 17.21M | 7.08M |
Retained Earnings | -21.48M | -19.55M | -17.85M | -16.08M | -13.52M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -2.71M | -1.43M | -182.50K | 1.13M | -6.44M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | 100.00 |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | 100.00 |
|
|||||
Total Common Equity | -2.71M | -1.43M | -182.50K | 1.13M | -6.44M |
Total Preferred Equity | -- | -- | -- | -- | 100.00 |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -2.71M | -1.43M | -182.50K | 1.13M | -6.44M |
|